BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:26 am Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 5,981,212 3.600% |
-1,574,376 (-20.84%) |
Filing |
| 2023-06-30 4:33 pm Purchase |
2023-06-22 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 7,555,588 7.100% |
5,745,039 (+317.31%) |
Filing |
| 2022-02-11 8:57 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 1,810,549 2.500% |
-1,946,500 (-51.81%) |
Filing |
| 2021-05-17 4:49 pm Purchase |
2021-05-06 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 3,757,049 5.100% |
3,757,049 (New Position) |
Filing |